{"id":"https://openalex.org/W7204995171","doi":"https://doi.org/10.1093/oncolo/oyag312.069","title":"68 LNK001 is a High-Fidelity AND-Logic-Gated CAR T Cell Therapy that Enables Precision Targeting of Clear Cell Renal Cell Carcinoma (ccRCC): Target Discovery and Validation for the ATHENA Phase 1 Trial","display_name":"68 LNK001 is a High-Fidelity AND-Logic-Gated CAR T Cell Therapy that Enables Precision Targeting of Clear Cell Renal Cell Carcinoma (ccRCC): Target Discovery and Validation for the ATHENA Phase 1 Trial","publication_year":2026,"publication_date":"2026-09-01","ids":{"openalex":"https://openalex.org/W7204995171","doi":"https://doi.org/10.1093/oncolo/oyag312.069"},"language":"en","primary_location":{"id":"doi:10.1093/oncolo/oyag312.069","doi":"https://doi.org/10.1093/oncolo/oyag312.069","is_oa":true,"landing_page_url":"https://doi.org/10.1093/oncolo/oyag312.069","pdf_url":"https://academic.oup.com/oncolo/article-pdf/31/Supplement_3/oyag312.069/70843990/oyag312.069.pdf","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://academic.oup.com/oncolo/article-pdf/31/Supplement_3/oyag312.069/70843990/oyag312.069.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031153138","display_name":"Alexander J. Bankovich","orcid":"https://orcid.org/0000-0003-2368-4479","observed_orcids":["https://orcid.org/0000-0003-2368-4479"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexander Bankovich","raw_affiliation_strings":["Link Cell Therapies , Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Link Cell Therapies , Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Bryan Smith","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bryan Smith","raw_affiliation_strings":["Link Cell Therapies , Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Link Cell Therapies , Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Colin Farrell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Colin Farrell","raw_affiliation_strings":["Link Cell Therapies , Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Link Cell Therapies , Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077151236","display_name":"Angeles Estell\u00e9s","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angeles Estelles","raw_affiliation_strings":["Link Cell Therapies , Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Link Cell Therapies , Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072045494","display_name":"Janette E. Sutton","orcid":"https://orcid.org/0000-0002-4580-9319","observed_orcids":["https://orcid.org/0000-0002-4580-9319"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Janette Sutton","raw_affiliation_strings":["Link Cell Therapies , Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Link Cell Therapies , Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5149008096","display_name":"Zeynep Wheeler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zeynep Wheeler","raw_affiliation_strings":["Link Cell Therapies , Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Link Cell Therapies , Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064574141","display_name":"Kazuteru Hasegawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kazuteru Hasegawa","raw_affiliation_strings":["Link Cell Therapies , Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Link Cell Therapies , Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148999006","display_name":"Benjamin Bauer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benjamin Bauer","raw_affiliation_strings":["Link Cell Therapies , Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Link Cell Therapies , Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5140135691","display_name":"Jakob McBroome","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jakob McBroome","raw_affiliation_strings":["Link Cell Therapies , Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Link Cell Therapies , Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030284065","display_name":"Diego A. Vargas\u2010Inchaustegui","orcid":"https://orcid.org/0000-0001-7405-9572","observed_orcids":["https://orcid.org/0000-0001-7405-9572"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Diego Vargas-Inchaustegui","raw_affiliation_strings":["Link Cell Therapies , Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Link Cell Therapies , Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111387409","display_name":"Regina Lin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Regina Lin","raw_affiliation_strings":["Link Cell Therapies , Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Link Cell Therapies , Inc","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029249355","display_name":"Mark A. Wallet","orcid":"https://orcid.org/0000-0003-0802-9548","observed_orcids":["https://orcid.org/0000-0003-0802-9548"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Wallet","raw_affiliation_strings":["Link Cell Therapies , Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Link Cell Therapies , Inc","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3852,"currency":"USD","value_usd":3852},"apc_paid":{"value":3852,"currency":"USD","value_usd":3852},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.62635961,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"Supplement_3","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.003800000064074993,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.7630000114440918},{"id":"https://openalex.org/keywords/clear-cell-renal-cell-carcinoma","display_name":"clear cell renal cell carcinoma","score":0.9950000047683716},{"id":"https://openalex.org/keywords/caix","display_name":"CAIX","score":0.9769999980926514},{"id":"https://openalex.org/keywords/enpp3","display_name":"ENPP3","score":1.0},{"id":"https://openalex.org/keywords/on-target-off-tumor-toxicity","display_name":"on-target off-tumor toxicity","score":0.7450000047683716},{"id":"https://openalex.org/keywords/single-cell-rna-sequencing","display_name":"single-cell RNA sequencing","score":0.7360000014305115},{"id":"https://openalex.org/keywords/slp-76","display_name":"SLP-76","score":0.7279999852180481},{"id":"https://openalex.org/keywords/autologous-car-t-cell-therapy","display_name":"autologous CAR T-cell therapy","score":0.7760000228881836},{"id":"https://openalex.org/keywords/solid-tumor-immunotherapy","display_name":"solid tumor immunotherapy","score":0.7789999842643738},{"id":"https://openalex.org/keywords/athena-trial","display_name":"ATHENA trial","score":0.5419999957084656}],"concepts":[{"id":"https://openalex.org/C2781278892","wikidata":"https://www.wikidata.org/wiki/Q18556340","display_name":"Clear cell renal cell carcinoma","level":3,"score":0.7630000114440918},{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.6920999884605408},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5544999837875366},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.542900025844574},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.536899983882904},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5091999769210815},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4968999922275543},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.45989999175071716},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4090000092983246},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.367900013923645},{"id":"https://openalex.org/C19317047","wikidata":"https://www.wikidata.org/wiki/Q412037","display_name":"T-cell receptor","level":4,"score":0.362199991941452},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3359000086784363},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.335099995136261},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.33379998803138733},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.32739999890327454},{"id":"https://openalex.org/C10882517","wikidata":"https://www.wikidata.org/wiki/Q15268054","display_name":"Cell therapy","level":3,"score":0.3174999952316284},{"id":"https://openalex.org/C40722700","wikidata":"https://www.wikidata.org/wiki/Q1103544","display_name":"Cluster of differentiation","level":3,"score":0.3109999895095825},{"id":"https://openalex.org/C2908731994","wikidata":"https://www.wikidata.org/wiki/Q2509220","display_name":"Hematologic Neoplasms","level":3,"score":0.29809999465942383},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.29339998960494995},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.288100004196167},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.28279998898506165},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.2720000147819519},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.26249998807907104},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.260699987411499},{"id":"https://openalex.org/C189014844","wikidata":"https://www.wikidata.org/wiki/Q189118","display_name":"Cell type","level":3,"score":0.25940001010894775},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.25619998574256897}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/oncolo/oyag312.069","doi":"https://doi.org/10.1093/oncolo/oyag312.069","is_oa":true,"landing_page_url":"https://doi.org/10.1093/oncolo/oyag312.069","pdf_url":"https://academic.oup.com/oncolo/article-pdf/31/Supplement_3/oyag312.069/70843990/oyag312.069.pdf","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13535427","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13535427/pdf/oyag312.069.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncologist","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/oncolo/oyag312.069","doi":"https://doi.org/10.1093/oncolo/oyag312.069","is_oa":true,"landing_page_url":"https://doi.org/10.1093/oncolo/oyag312.069","pdf_url":"https://academic.oup.com/oncolo/article-pdf/31/Supplement_3/oyag312.069/70843990/oyag312.069.pdf","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7204995171.pdf","grobid_xml":"https://content.openalex.org/works/W7204995171.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7205007815","https://openalex.org/W4404064032","https://openalex.org/W3212625558","https://openalex.org/W7148867363","https://openalex.org/W4323546636","https://openalex.org/W4415444430","https://openalex.org/W4362541463","https://openalex.org/W2771473101","https://openalex.org/W4365511810","https://openalex.org/W4409629088"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Chimeric":[2],"antigen":[3],"receptor":[4],"(CAR)":[5],"T":[6,104,326],"cell":[7,101,108,193,201,209,327],"immunotherapies":[8],"have":[9,19,69],"shown":[10],"exciting":[11],"clinical":[12,388,401],"benefits":[13],"in":[14,21,33,50,171,176,226,392,397],"hematologic":[15],"malignancies,":[16],"whereas":[17],"challenges":[18],"persisted":[20],"addressing":[22],"solid":[23,34],"tumors.":[24],"A":[25],"key":[26],"reason":[27],"for":[28,102,115,267,302,358,387],"the":[29,78,98,124,218,235,242,289,309,385],"lack":[30],"of":[31,60,65,117,126,220,283,291,308,356,361,390],"success":[32],"tumors":[35],"is":[36,85,181],"on-target":[37],"off-tumor":[38],"(OTOT)":[39],"toxicity":[40,80],"that":[41,89,120,180,288,342],"has":[42],"previously":[43],"occurred":[44],"towards":[45],"targets":[46],"such":[47],"as":[48,234,318],"CAIX":[49,229,253,295,310,332],"ccRCC.":[51],"New":[52],"tools":[53],"are":[54,297],"required":[55],"to":[56,76,93,183,216,251,337],"enable":[57],"precise":[58],"targeting":[59,331,360],"malignant":[61,127,164,258,362],"cells":[62,128,161,366,377],"and":[63,106,162,230,245,254,259,263,271,311,354,394],"sparing":[64],"normal":[66,137,159,191,260,379],"tissues.":[67,380],"We":[68,167,195],"developed":[70,169,250,316],"Logic-gated":[71],"Intracellular":[72],"NetworK":[73],"(LINK)":[74],"technology":[75],"overcome":[77],"OTOT":[79,368],"challenge.":[81],"The":[82],"LINK":[83],"platform":[84,174],"a":[86,112,148,277,398],"Boolean":[87],"AND-gate":[88],"requires":[90],"two":[91,338],"antigens":[92],"be":[94,133],"simultaneously":[95],"present":[96,135],"on":[97,123,136,188,257,306],"same":[99],"target":[100,107,118,144,185,203,238,313,376],"CAR":[103,325],"activation":[105],"elimination.":[109],"This":[110],"creates":[111],"novel":[113],"paradigm":[114],"selection":[116],"pairs":[119],"only":[121],"co-occur":[122],"surface":[125,202,210],"even":[129],"though":[130],"they":[131],"may":[132],"individually":[134],"healthy":[138],"cells.":[139,166,261],"Methods":[140],"To":[141,240],"identify":[142],"suitable":[143],"pairs,":[145,204],"we":[146,315],"assembled":[147],"rich,":[149],"highly-curated":[150],"single-cell":[151,177],"RNAseq":[152,178],"data":[153,179],"set":[154],"representing":[155,378],"over":[156,197],"29":[157],"million":[158,199],"human":[160],"390,000":[163],"ccRCC":[165,285,365,396],"further":[168],"an":[170,319],"silico":[172,227],"analytics":[173],"anchored":[175],"used":[182],"assess":[184,217],"pair":[186],"co-expression":[187,268],"tumor,":[189],"versus":[190],"tissue":[192],"types.":[194],"scored":[196],"28":[198],"potential":[200],"generated":[205],"from":[206],"approximately":[207],"7,500":[208],"proteins,":[211],"across":[212],"our":[213],"curated":[214],"dataset":[215],"quality":[219,237],"this":[221],"association.":[222],"Results":[223],"Through":[224],"detailed":[225],"analyses,":[228],"ENPP3":[231,255,312,334],"were":[232,249,335],"selected":[233],"highest":[236],"pair.":[239],"validate":[241],"pair,":[243,314],"IHC":[244,262],"flow":[246,264],"cytometry":[247,265],"assays":[248],"characterize":[252],"expression":[256,296],"analyzed":[266],"within":[269,272],"patients":[270,292],"each":[273],"cells,":[274],"respectively":[275],"demonstrated":[276],"strong":[278],"therapeutic":[279],"potential.":[280],"Further":[281],"analysis":[282],"419":[284],"cores":[286],"shows":[287],"84%":[290],"with":[293],"high":[294,301],"almost":[298],"universally":[299],"(99%)":[300],"ENPP3.":[303],"Conclusions":[304],"Based":[305],"validation":[307],"LNK001":[317,357,391],"AND-logic-gated":[320],"autologous":[321],"ex":[322],"vivo":[323],"engineered":[324],"therapy.":[328],"Binder":[329],"domains":[330],"or":[333,345,373],"fused":[336],"separate":[339],"synthetic":[340],"receptors":[341],"utilize":[343],"SLP76":[344],"LAT":[346],"signaling":[347],"domains,":[348],"respectively.":[349],"Preclinical":[350],"studies":[351,383],"demonstrate":[352],"safety":[353],"efficacy":[355],"selective":[359],"CAIX+":[363,371],"ENPP3+":[364,375],"without":[367],"activity":[369],"against":[370],"ENPP3-":[372],"CAIX-":[374],"Collectively,":[381],"these":[382],"form":[384],"basis":[386],"development":[389],"advanced":[393],"metastatic":[395],"phase":[399],"1":[400],"trial.":[402]},"counts_by_year":[],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2026-09-02T00:00:00"}